Working... Menu
Trial record 6 of 48 for:    Dovitinib

Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02268435
Recruitment Status : Withdrawn (Dovitinib Production stopped)
First Posted : October 20, 2014
Last Update Posted : August 4, 2015
Information provided by (Responsible Party):
Yoon-Koo Kang, Asan Medical Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : August 2016
  Estimated Study Completion Date : November 2016